rnlxture was added to a reaction mixture containing I00 mM Scdium octanoate in an 0.2 M solution was administered to rabbits by continuous slow IV infusion over 4 hr. Controls were given identical infusions of normal saline. The animals were then sacrificed, brains were removed, and specific areas were isolated and assayed for Na'K' ATPase activity. Significant inhibition of regional Na'K+ ATPase activity was detected in cortex. thalamus. hypothalamus. pons, and medulla of rabbits given octanoate when compared to controls.
;isnlM inorganic phosphorus released per min per mg protein. produce coma in patients with Reye's syndrome and hepatic S u u n~ octanoiite concentrations were determined as described encephalopathy by inhibition of cerebral Na+K+ ATPase activity pKviously (9).
with resultant disruption of normal transport across neuronal and glial membranes. K tSU LI'S No significant alterations in blood pressure or partial pressure continuous I V infusion of the short-chain fatty acid sodium of oxygen were observed durlng the 4-hr period of octanoate octanoate into unanesthetlzed prc,duces hyper-inl'usion. Marked hyperventilat~on and hyputonia were observed coma, se,Lures, hypotonia, and electroencephaloin rabbits treated with octanoate and were similar to findings gr;,phic changes ( 1 ) ) . l-he (he cenlr;,l ncrreported previously (9). Pupillary dilatation was also observed in vous system are unknown, one report ( 1 , dl exper~rnental an~rnals. Mean concentration 01' oclanoate In suggested that octanoale inhibited N~+ K + AT^^^^ in rat blood at the end of 4 hr was 380 pmoles/liter. brain slices in v,,ro, no effort was made to identify N a t K ' ATPase activity was assayed in cortex, hypothalamus.
differences. nor have , , , , , , , , , , studies been th;iIan~us. basal pons, tegmental pons. and medulla. In every area formed, ~h~ present study was designed to examine of brain examined. ATPase activity was s~gnlficantly reduced N~+ K + AT^^^^ in rabbit brain v,vo fi)1lowing a contln-con1p;ired to activity measured in control brains (Table I ) . uous 1V infusion of octanoate.
OISC'USSION M.4'I'LKIALS AN11 MLTIIOIIS
The clinical effects of short-chain fatty acid administration on Two-kg albino rabbits were prepared accord~ng to the experiexperimental anlrnals arc btriklng. Hyperventilation to a respiramental protocol described In detail in a previous report (9). An tory rate of 240 (from a baseline of 90) IS a conslster~t linding. 0.2 M solution of sodium octanoate was infused at a rate of 0. I9 Hypotonia. unresponsiveness, seizures, and pupillary dilation also ml/min over a 4-hr period through the ear vein. Control animals occur. Recent studies in this laboratory have suggested that octawere given continuous infusions of normal saline. At the end of noate may alter blood-brain barrier permeability to injected Ithe four-hr period. the animals received a rapid IV injection of DOPA in rats (8). The present observation ofinhibition ofreglonal 100 mg sodium pentobarbitol. and the brains were immediately cerebral N a ' K ' ATPase activity in rabbits in viva is significant exposed. removed. and placed on ice. Under a dissecting microbecause it provides one mechanism by which octanoate produces scope. sections of approximately 50 to 100 mg were isolated its toxic effects on the central nervous system. N a ' K * ATPase is rapidly. fiozen on dry ice. and weighed. Each sample was mixed thought lo regulate ion transport across cell membranes ( 7 ) . with distilled water in a 20: 1 ratio of water to brain by volume.
Interference with normal i o n~c transport across neuronal and glial (In preliminary studies in this laboratory. no difference in ATPase membranes could certainly result in coma and seilures. Such activity was found using water or deoxycholate: it was thus decided interference could also result in a loss of functional integr~ty of to use water). This mixture was then homogenized in a glass the blood-brain barrier. homogeni~er with a Teflon pestle for 50 strokes at 4OC and This observation has implications Sor several human metabolic centrifuged for 10 min at 400 x g and 4°C. and the supernatant and toxic encephalopath~es In which short-chain fatty acld elevawas frozen and used for ATPase determination. ATPase wax tions have been reported. Reye's syndrome is an acute encephameasured by a modification of the method of Samson and Quinn lopathy in children which presents with coma, sei~ures. and hy-(6). Total ATPase activity was measured by taking 0.2 ml of the pervent~lation. Serum short-chain fatty acid elevations (including supernatant and adding 0.2 ml of 50 rnM Tris buffer. pH 7.8. This octanoic acid) are observed in these patients (5. 10) and appear to S J J RE<;IONAL ('EKEBRAL Na'K' ACTIVITY ' tr, nuniher of s a m p l e s in e a c h group.
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-' One-tatled Student's l test.
' u + S.1).
correlate with the severity of the illness ( 1 I ) . Patients with hepatic encephalopathy from a variety of causes also have elevated serum a n d cerebrospinal fluid concentrations of short-chain fatty acids (3). After a 4-hr infusion o f octanoate. serum concentrations of this substance are of the same order of magnitude as are those in patients with Reye's syndrome ( 5 ) . suggesting that the concentrations of fatty acids in these patients may be high enough to account Ibr the clinical syrnptomatology. T h e fact that the shortc h a~n fatty acid sodium octanoate inhibits N a ' K t ATPase activity in experimental animal5 suggests that this may be a possible mechanism for these human encephalopathies. Further studies are required to identify potential therapeutic agents to counteract the toxic effects ofexcess short-chain fatty acids on the central nervous system. 
ERRATUM
In the a r t~c l e by Lee er (11. "Genetic Influence on Serum IgI) Levels" in Pc~iiarric Re.search. 13: 60 ( 1980) . the value of the variance of monwygote pairs in the Igll level was incorrectly printed. T h e correct value is 0.03. W e regret the error.
